Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Lignende værker

• Anti‐Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial
  af: Ajala, Oluremi N., et al.
  Udgivet: (2020)
• Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis from the JUPITER Trial
  af: Khera, Amit V., et al.
  Udgivet: (2013)
• On-Treatment Non-HDL Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk after Treatment with Potent Statin Therapy: The JUPITER Trial
  af: Mora, Samia, et al.
  Udgivet: (2012)
• Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial
  af: Akinkuolie, Akintunde O., et al.
  Udgivet: (2016)
• The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial
  af: Novack, Victor, et al.
  Udgivet: (2012)